成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 369-35-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 369-35-7
Chemical Structure| 369-35-7
Structure of 369-35-7 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 369-35-7 ]

Related Doc. of [ 369-35-7 ]

Alternatived Products of [ 369-35-7 ]
Product Citations

Product Citations

Flavio S.P. Cardoso ; Appasaheb L. Kadam ; Ryan C. Nelson , et al. DOI: PubMed ID:

Abstract: A low-cost, protecting group-free route to 6-(2-fluoro-4-nitrophenyl)-2-oxa-6-azaspiro[3.3]heptane (1), the starting material for the in-development tuberculosis treatment TBI-223, is described. The key bond forming step in this route is the creation of the azetidine ring through a hydroxide-facilitated alkylation of 2-fluoro-4-nitroaniline (2) with 3,3-bis(bromomethyl)oxetane (BBMO, 3). After optimization, this ring formation reaction was demonstrated at 100 g scale with isolated yield of 87% and final product purity of >99%. The alkylating agent 3 was synthesized using an optimized procedure that starts from tribromoneopentyl alcohol (TBNPA, 4), a commercially available flame retardant. Treatment of 4 with sodium hydroxide under Schotten–Baumann conditions closed the oxetane ring, and after distillation, 3 was recovered in 72% yield and >95% purity. This new approach to compound 1 avoids the previous drawbacks associated with the synthesis of 2-oxa-6-azaspiro[3,3]heptane (5), the major cost driver used in previous routes to TBI-223. The optimization and multigram scale-up results for this new route are reported herein.

Keywords: tuberculosis ; TBI-223 ; azaspiro[3.3]heptane ; spiroamine

Purchased from AmBeed: ; ; 1522-92-5 ;

Product Details of [ 369-35-7 ]

CAS No. :369-35-7 MDL No. :MFCD00034560
Formula : C6H5FN2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :LETNCFZQCNCACQ-UHFFFAOYSA-N
M.W : 156.12 Pubchem ID :101254
Synonyms :

Calculated chemistry of [ 369-35-7 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 39.63
TPSA : 71.84 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.35 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.99
Log Po/w (XLOGP3) : 1.27
Log Po/w (WLOGP) : 1.74
Log Po/w (MLOGP) : 0.7
Log Po/w (SILICOS-IT) : -0.59
Consensus Log Po/w : 0.82

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.95
Solubility : 1.77 mg/ml ; 0.0113 mol/l
Class : Very soluble
Log S (Ali) : -2.38
Solubility : 0.654 mg/ml ; 0.00419 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.69
Solubility : 3.22 mg/ml ; 0.0207 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 3.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.85

Safety of [ 369-35-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280 UN#:N/A
Hazard Statements:H302-H312-H332 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 369-35-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 369-35-7 ]

[ 369-35-7 ] Synthesis Path-Downstream   1~2

  • 1
  • [ 369-35-7 ]
  • [ 13790-39-1 ]
  • [ 849217-39-6 ]
YieldReaction ConditionsOperation in experiment
80% With hydrogenchloride; In acetonitrile;Heating / reflux; A mixture of 4- chloro-6,7-dimethoxy-quinazoline (548mg, 2. 4mmol), 2-fluoro-4-nitro-phenylamine (392mg, 2. 5mmol), AcCN (10ML), and conc'd HC1 (O. 050ml) was heated to reflux for several hrs. After the reaction mixture was allowed to cool to room temperature, the resulting solids were filtered, washed with AcCN and air-dried to give (6,7-dimethoxy- QUINAZOLIN-4-YL)- (2-FLUORO-4-NITRO-PHENYL)-AMINE (673mgs, 80%).
69% With caesium carbonate; In N,N-dimethyl-formamide; at 90℃; Step 1. N-(2-fluoro-4-nitrophenyl)-6,7-dimethoxyquinazolin-4-amine (41) A stirred suspension of <strong>[13790-39-1]4-chloro-6,7-dimethoxyquinazoline</strong> (40) (prepared according to A. J. Bridges et al., J. Med. Chem., 1996, 39, 267) (1.00 g, 4.45 mmol), 2-fluoro-4-nitroaniline (940 mg, 6.02 mmol) and cesium carbonate (3.20 g, 9.82 mmol) in anhydrous DMF (20 mL) was heated at 90 C. overnight under nitrogen. The reaction mixture was allowed to cool to room temperature. The reaction mixture was diluted with AcOEt, successively washed with water and a saturated solution of ammonium chloride, concentrated and triturated with AcOEt/hexanes. After filtration, the cake was adsorbed on silica gel and purified by flash column chromatography on (eluents MeOH/DCM: 2/98→10/90) to afford the title compound 41 (1.06 g, 69% yield) as a yellow-green solid. MS (m/z): 345.0 (M+H).
  • 2
  • [ 188187-03-3 ]
  • [ 369-35-7 ]
  • C14H8ClFN2O3 [ No CAS ]
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 369-35-7 ]

Fluorinated Building Blocks

Chemical Structure| 2369-13-3

[ 2369-13-3 ]

3-Fluoro-4-nitroaniline

Similarity: 0.96

Chemical Structure| 1493-27-2

[ 1493-27-2 ]

1-Fluoro-2-nitrobenzene

Similarity: 0.94

Chemical Structure| 446-35-5

[ 446-35-5 ]

2,4-Difluoro-1-nitrobenzene

Similarity: 0.92

Chemical Structure| 2369-12-2

[ 2369-12-2 ]

3-Fluoro-5-nitroaniline

Similarity: 0.92

Chemical Structure| 402-67-5

[ 402-67-5 ]

1-Fluoro-3-nitrobenzene

Similarity: 0.92

Aryls

Chemical Structure| 2369-13-3

[ 2369-13-3 ]

3-Fluoro-4-nitroaniline

Similarity: 0.96

Chemical Structure| 1493-27-2

[ 1493-27-2 ]

1-Fluoro-2-nitrobenzene

Similarity: 0.94

Chemical Structure| 446-35-5

[ 446-35-5 ]

2,4-Difluoro-1-nitrobenzene

Similarity: 0.92

Chemical Structure| 2369-12-2

[ 2369-12-2 ]

3-Fluoro-5-nitroaniline

Similarity: 0.92

Chemical Structure| 402-67-5

[ 402-67-5 ]

1-Fluoro-3-nitrobenzene

Similarity: 0.92

Amines

Chemical Structure| 2369-13-3

[ 2369-13-3 ]

3-Fluoro-4-nitroaniline

Similarity: 0.96

Chemical Structure| 2369-12-2

[ 2369-12-2 ]

3-Fluoro-5-nitroaniline

Similarity: 0.92

Chemical Structure| 113269-06-0

[ 113269-06-0 ]

4-Fluoro-5-nitrobenzene-1,2-diamine

Similarity: 0.90

Chemical Structure| 17809-36-8

[ 17809-36-8 ]

2-Fluoro-6-nitroaniline

Similarity: 0.90

Chemical Structure| 211693-73-1

[ 211693-73-1 ]

2,3-Difluoro-6-nitroaniline

Similarity: 0.89

Nitroes

Chemical Structure| 2369-13-3

[ 2369-13-3 ]

3-Fluoro-4-nitroaniline

Similarity: 0.96

Chemical Structure| 1493-27-2

[ 1493-27-2 ]

1-Fluoro-2-nitrobenzene

Similarity: 0.94

Chemical Structure| 446-35-5

[ 446-35-5 ]

2,4-Difluoro-1-nitrobenzene

Similarity: 0.92

Chemical Structure| 2369-12-2

[ 2369-12-2 ]

3-Fluoro-5-nitroaniline

Similarity: 0.92

Chemical Structure| 402-67-5

[ 402-67-5 ]

1-Fluoro-3-nitrobenzene

Similarity: 0.92

; ;